ABCC8
ATP-binding cassette sub-family C member 8
Also known as: ABC36, ABCC8_HUMAN, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q09428
- Gene
- ABCC8
- Ensembl
- ENSG00000006071
- Chromosome
- 11
- Canonical length
- 1581 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoli,Golgi apparatus,Cytosol,Principal piece
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
1581 residues, UniProt reviewed canonical sequence.
>Q09428|ABCC8
1 MPLAFCGSEN HSAAYRVDQG VLNNGCFVDA LNVVPHVFLL FITFPILFIG WGSQSSKVHI
61 HHSTWLHFPG HNLRWILTFM LLFVLVCEIA EGILSDGVTE SHHLHLYMPA GMAFMAAVTS
121 VVYYHNIETS NFPKLLIALL VYWTLAFITK TIKFVKFLDH AIGFSQLRFC LTGLLVILYG
181 MLLLVEVNVI RVRRYIFFKT PREVKPPEDL QDLGVRFLQP FVNLLSKGTY WWMNAFIKTA
241 HKKPIDLRAI GKLPIAMRAL TNYQRLCEAF DAQVRKDIQG TQGARAIWQA LSHAFGRRLV
301 LSSTFRILAD LLGFAGPLCI FGIVDHLGKE NDVFQPKTQF LGVYFVSSQE FLANAYVLAV
361 LLFLALLLQR TFLQASYYVA IETGINLRGA IQTKIYNKIM HLSTSNLSMG EMTAGQICNL
421 VAIDTNQLMW FFFLCPNLWA MPVQIIVGVI LLYYILGVSA LIGAAVIILL APVQYFVATK
481 LSQAQRSTLE YSNERLKQTN EMLRGIKLLK LYAWENIFRT RVETTRRKEM TSLRAFAIYT
541 SISIFMNTAI PIAAVLITFV GHVSFFKEAD FSPSVAFASL SLFHILVTPL FLLSSVVRST
601 VKALVSVQKL SEFLSSAEIR EEQCAPHEPT PQGPASKYQA VPLRVVNRKR PAREDCRGLT
661 GPLQSLVPSA DGDADNCCVQ IMGGYFTWTP DGIPTLSNIT IRIPRGQLTM IVGQVGCGKS
721 SLLLAALGEM QKVSGAVFWS SLPDSEIGED PSPERETATD LDIRKRGPVA YASQKPWLLN
781 ATVEENIIFE SPFNKQRYKM VIEACSLQPD IDILPHGDQT QIGERGINLS GGQRQRISVA
841 RALYQHANVV FLDDPFSALD IHLSDHLMQA GILELLRDDK RTVVLVTHKL QYLPHADWII
901 AMKDGTIQRE GTLKDFQRSE CQLFEHWKTL MNRQDQELEK ETVTERKATE PPQGLSRAMS
961 SRDGLLQDEE EEEEEAAESE EDDNLSSMLH QRAEIPWRAC AKYLSSAGIL LLSLLVFSQL
1021 LKHMVLVAID YWLAKWTDSA LTLTPAARNC SLSQECTLDQ TVYAMVFTVL CSLGIVLCLV
1081 TSVTVEWTGL KVAKRLHRSL LNRIILAPMR FFETTPLGSI LNRFSSDCNT IDQHIPSTLE
1141 CLSRSTLLCV SALAVISYVT PVFLVALLPL AIVCYFIQKY FRVASRDLQQ LDDTTQLPLL
1201 SHFAETVEGL TTIRAFRYEA RFQQKLLEYT DSNNIASLFL TAANRWLEVR MEYIGACVVL
1261 IAAVTSISNS LHRELSAGLV GLGLTYALMV SNYLNWMVRN LADMELQLGA VKRIHGLLKT
1321 EAESYEGLLA PSLIPKNWPD QGKIQIQNLS VRYDSSLKPV LKHVNALIAP GQKIGICGRT
1381 GSGKSSFSLA FFRMVDTFEG HIIIDGIDIA KLPLHTLRSR LSIILQDPVL FSGTIRFNLD
1441 PERKCSDSTL WEALEIAQLK LVVKALPGGL DAIITEGGEN FSQGQRQLFC LARAFVRKTS
1501 IFIMDEATAS IDMATENILQ KVVMTAFADR TVVTIAHRVH TILSADLVIV LKRGAILEFD
1561 KPEKLLSRKD SVFASFVRAD KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABCC8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 17
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 23 nTPM
- cerebellum: 22 nTPM
- cerebral cortex: 14 nTPM
- pancreas: 13 nTPM
- hippocampal formation: 9.2 nTPM
- basal ganglia: 7.7 nTPM
Single-cell type
- pancreatic islet cells: 264 nCPM
- adrenal medulla cells: 192 nCPM
- gonadotrophs: 90 nCPM
- retinal bipolar cells: 75 nCPM
- somatotrophs: 70 nCPM
- corticotrophs: 66 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 11 nTPM
- white matter: 8.9 nTPM
- pons: 8.4 nTPM
- basal ganglia: 8.2 nTPM
- cerebellum: 8.2 nTPM
- hippocampal formation: 8.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ABCC8.
Disease | AllUniProt
Conditions ABCC8 is implicated in, by any mechanism.
- Leucine-induced hypoglycemia (LIH) MIM:240800
- Hyperinsulinemic hypoglycemia, familial, 1 (HHF1) MIM:256450
- Diabetes mellitus, permanent neonatal, 3 (PNDM3) MIM:618857
- Transient neonatal diabetes mellitus 2 (TNDM2) MIM:610374
- Maturity-onset diabetes of the young 12 (MODY12) MIM:621196
Disease | GeneticClinVar
481 pathogenic / likely-pathogenic of 2,963 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyperinsulinemic hypoglycemia, familial, 1
- Type 2 diabetes mellitus
- Hereditary hyperinsulinism
- Diabetes mellitus, permanent neonatal 3
- Diabetes mellitus, transient neonatal, 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.91
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- cellular response to nutrient levels
- female pregnancy
- glutamate secretion, neurotransmission
- inorganic cation transmembrane transport
- intracellular glucose homeostasis
- memory
- negative regulation of angiogenesis
- negative regulation of blood-brain barrier permeability
- negative regulation of glial cell proliferation
- negative regulation of insulin secretion
- negative regulation of low-density lipoprotein particle clearance
- neuromuscular process
- positive regulation of insulin secretion involved in cellular response to glucose stimulus
- positive regulation of potassium ion transport
- positive regulation of tight junction disassembly
- positive regulation of tumor necrosis factor production
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- potassium ion transport
- regulation of insulin secretion
- response to insulin
- response to lipopolysaccharide
- response to pH
- response to xenobiotic stimulus
- response to zinc ion
- transmembrane transport
- visual learning
- negative regulation of neuroblast migration
- positive regulation of uterine smooth muscle relaxation
Molecular functions
- ABC-type transporter activity
- ADP binding
- ATP binding
- ATP hydrolysis activity
- ATP-activated inward rectifier potassium channel activity
- ATPase-coupled monoatomic cation transmembrane transporter activity
- metal ion binding
- potassium channel activity
- sulfonylurea receptor activity
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP-binding cassette sub-family C member 8/9
- ABC transporter-like, ATP-binding domain
- AAA+ ATPase domain
- ABC transporter type 1, transmembrane domain
- ABC transporter-like, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- ABC transporter type 1, transmembrane domain superfamily
- ATP-binding cassette transporter C-like
- ABC transporter
- ABC transporter transmembrane region
- ATP-binding cassette subfamily C member 8
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ABCC8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABCC8 as an antibody target. Whether an autoantibody or antibody against ABCC8 could matter depends on whether native ABCC8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABCC8 is annotated at the cell surface, where native ABCC8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ABCC8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...